Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited
CSL Limited (OTC: CSLLY) is a global biopharma company with a dynamic portfolio of medicines. CSL uses its expertise in plasma-derived therapies, vaccines and biotechnology to deliver medicines for serious and complex diseases such as hemophilia, immune deficiencies, influenza, and iron deficiency anaemia. CSL employees over 29,000 people globally and is headquartered in
In addition to specializing in administering cross-border equity structures such as New York Shares and American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. Deutsche Bank offers a very broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.
* This information was provided by CSL Limited (January 2026).
Depositary Receipt Information |
Depositary Receipt Contacts |
||||||||
Country |
|
New Business
Nicole Pfundstein |
|
||||||
Custodian Bank |
BNP Paribas S.A., Level 6, 60 Castlereagh Street, |
Tel: +61 2 8258 1019 |
|
||||||
|
|
Markets Distribution |
|||||||
|
|
|
|||||||
Effective Date |
January 27, 2026 |
|
Tel: +44 (0) 20 7547 6500 |
||||||
|
|
gtb.db.com |
|
||||||
Level I ADR |
|
|
Tel: +1 212 250 9100 |
||||||
CUSIP |
12637N204 |
|
|
||||||
ISIN |
US12637N2045 |
|
|
||||||
Symbol |
|
|
|||||||
Exchange |
OTC |
|
|
||||||
Current Ratio |
2 ADSs: 1 ordinary share |
|
|
||||||
Eligibility |
DTC |
|
|
||||||
Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, with a strong position in
The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act"). The investment or investment service which is the subject of this notice is not available to retail clients as defined by the
View source version on businesswire.com: https://www.businesswire.com/news/home/20260127811801/en/
For further information, please contact:
Deutsche Bank AG
Press & Media Relations
Dylan Riddle
Tel. +12122504982
Cell. +1(904)3866481
Email dylan.riddle@db.com
Source: Deutsche Bank